Clinical trial
Evaluation of the Efficacy of Injections of Botulinic Toxin in Plantar Lesions of Patients Suffering From Localized Epidermolysis Bullosa Simplex : Double Blind Randomized Controlled Study.
NCT03453632 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Efficacy of Injections of Botulinic Toxin in Plantar Lesions of Patients Suffering From Localized Epidermolysis Bullosa Simplex : Double Blind Randomized Controlled Study.
- Lead sponsor
- University Hospital, Toulouse
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- June 14, 2018
- Completion date
- January 21, 2025
- Enrollment
- 18 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.